Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
NTLA
Intellia Therapeutics, Inc.
NASDAQ · In Vitro & In Vivo Diagnostic Substances
Last close
$12.06
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
In Vitro & In Vivo Diagnostic Substances
Market cap
$1.69B
RECENT INSIDER TRADES
2026-10-06
· Dube Michael P
(VP, Chief Accounting Officer)
· SELL
2026-08-24
· LEONARD JOHN M
(President and CEO)
· SELL
2026-07-24
· Dulac Edward J III
(EVP, Chief Financial Officer)
· SELL
2026-07-06
· Dulac Edward J III
(EVP, Chief Financial Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
356
Shares held
171,700,808
Value
$2.77B
Percent of shares outstanding
122.53%
As of quarter end
2026-06-30
RECENT NEWS
Intellia Therapeutics awards inducement grants to eight new employees
Intellia Therapeutics Bears Growl Again, This Time About Claude AI -- Yawn!
Intellia Therapeutics presents at Morgan Stanley healthcare conference
Intellia Therapeutics, Inc. · 8-K (7.01,8.01,9.01)
Intellia Therapeutics, Inc. · 8-K (1.01,2.03,7.01,9.01)
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Intellia Therapeutics, Inc. (NTLA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit